quantisnow
FeedTopReportsPricing
⌘K
Live feed
19:01:22·69d
INSIDERFiling
Hyliion Holdings Corp. logo

Director Freeland Richard Joseph was granted 60,976 shares, increasing direct ownership by 27% to 283,774 units (SEC Form 4)

HYLN· Hyliion Holdings Corp.
Consumer Discretionary
Original source

Companies

  • HYLN
    Hyliion Holdings Corp.
    Consumer Discretionary

Recent analyst ratings

  • Oct 21UpdateJohnson Rice-
  • Oct 12UpdateNorthland Capital$1.50
  • Nov 22UpdateNorthland Capital$4.00
  • Aug 11UpdateCantor Fitzgerald$5.00
  • Jun 21UpdateJP Morgan-
  • Mar 10UpdateBarclays$4.00

Related

  • INSIDER44d
    SEC Form 4 filed by Hyliion Holdings Corp.
  • SEC49d
    SEC Form EFFECT filed by Hyliion Holdings Corp.
  • INSIDER50d
    Chief Accounting Officer. Standley Greg disposed of $15,118 worth of shares (7,411 units at $2.04), decreasing direct ownership by 3% to 261,280 units (SEC Form 4)
  • INSIDER50d
    Chief Commercial Officer Ramasamy Govindaraj disposed of $26,026 worth of shares (12,758 units at $2.04), decreasing direct ownership by 2% to 607,235 units (SEC Form 4)
  • INSIDER50d
    Chief Legal&Compliance Officer Oxholm Jose Miguel disposed of $50,796 worth of shares (24,900 units at $2.04), decreasing direct ownership by 3% to 823,370 units (SEC Form 4)
  • INSIDER50d
    Chief Technology Officer Mook Joshua T. disposed of $30,225 worth of shares (14,816 units at $2.04), decreasing direct ownership by 1% to 1,114,109 units (SEC Form 4)
  • INSIDER50d
    Chief Strategy Officer Lantz Cheri disposed of $34,068 worth of shares (16,700 units at $2.04), decreasing direct ownership by 2% to 730,204 units (SEC Form 4)
  • INSIDER50d
    Chief Financial Officer Panzer Jon disposed of $34,313 worth of shares (16,820 units at $2.04), decreasing direct ownership by 2% to 957,140 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022